Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Merli

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
Haematologica|September 2, 2004
Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano LinfomiFrancesco Merli, Marilena Bertini, Stefano Luminari, et al.
Leukemia & Lymphoma|March 2, 2016
Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapyPatrizia Ciammella, Andrea Riccardo Filippi, Gabriele Simontacchi, et al.
British Journal of Haematology|May 16, 2020
Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphomaFulvio Massaro, Yana Stepanishyna, Martina Manni, et al.
Leukemia & Lymphoma|December 30, 2009
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio LinfomiDonato Mannina, Stefano Luminari, Alessandra Dondi, et al.
Cancer|November 25, 2003
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio LinfomiPaolo G Gobbi, Chiara Broglia, Francesco Merli, et al.
International Journal of Radiation Oncology, Biology, Physics|June 3, 2015
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus RadiotherapyGabriele Simontacchi, Andrea Riccardo Filippi, Patrizia Ciammella, et al.
Frontiers in Oncology|September 28, 2023
Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & Società Italiana della Riproduzione UmanaCarla Minoia, Simonetta Viviani, Erica Silvestris, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Primary Diffuse Large B-Cell Lymphoma of the Urinary Bladder: Update on a Rare Disease and Potential Diagnostic PitfallsMagda Zanelli, Francesca Sanguedolce, Maurizio Zizzo, et al.
Frontiers in Nutrition|May 24, 2021
Prognostic Impact of Muscle Quantity and Quality and Fat Distribution in Diffuse Large B-Cell Lymphoma PatientsGiulia Besutti, Fulvio Massaro, Efrem Bonelli, et al.
British Journal of Haematology|December 2, 2017
Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfitMaria Christina Cox, Gerardo Musuraca, Roberta Battistini, et al.
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
Haematologica|September 2, 2004
Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano LinfomiFrancesco Merli, Marilena Bertini, Stefano Luminari, et al.
Leukemia & Lymphoma|March 2, 2016
Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapyPatrizia Ciammella, Andrea Riccardo Filippi, Gabriele Simontacchi, et al.
British Journal of Haematology|May 16, 2020
Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphomaFulvio Massaro, Yana Stepanishyna, Martina Manni, et al.
Leukemia & Lymphoma|December 30, 2009
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio LinfomiDonato Mannina, Stefano Luminari, Alessandra Dondi, et al.
Cancer|November 25, 2003
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio LinfomiPaolo G Gobbi, Chiara Broglia, Francesco Merli, et al.
International Journal of Radiation Oncology, Biology, Physics|June 3, 2015
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus RadiotherapyGabriele Simontacchi, Andrea Riccardo Filippi, Patrizia Ciammella, et al.
Frontiers in Oncology|September 28, 2023
Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & Società Italiana della Riproduzione UmanaCarla Minoia, Simonetta Viviani, Erica Silvestris, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Primary Diffuse Large B-Cell Lymphoma of the Urinary Bladder: Update on a Rare Disease and Potential Diagnostic PitfallsMagda Zanelli, Francesca Sanguedolce, Maurizio Zizzo, et al.
Frontiers in Nutrition|May 24, 2021
Prognostic Impact of Muscle Quantity and Quality and Fat Distribution in Diffuse Large B-Cell Lymphoma PatientsGiulia Besutti, Fulvio Massaro, Efrem Bonelli, et al.
British Journal of Haematology|December 2, 2017
Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfitMaria Christina Cox, Gerardo Musuraca, Roberta Battistini, et al.
Pageof 16